Los Angeles Capital Management’s Insmed INSM Stock Holding History

Los Angeles Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.59M	Buy	43,092 +42,156	+4,504%	+$5.1M	0.02%	438
2026 Q1	$153K	Sell	936 -81,449	-99%	-$12.5M	﹤0.01%	1213
2025 Q4	$16M	Sell	82,385 -45,118	-35%	-$8.23M	0.05%	193
2025 Q3	$18.4M	Sell	127,503 -203,297	-61%	-$24.9M	0.06%	195
2025 Q2	$33.3M	Buy	330,800 +318,716	+2,638%	+$24.4M	0.12%	134
2025 Q1	$922K	Buy	12,084 +2,879	+31%	+$220K	﹤0.01%	590
2024 Q4	$636K	Sell	9,205 -974	-10%	-$70.1K	﹤0.01%	749
2024 Q3	$743K	Buy	10,179 +6,335	+165%	+$468K	﹤0.01%	744
2024 Q2	$258K	Buy	+3,844	New	+$149K	﹤0.01%	1065
2021 Q2	–	Sell	-20,256	Closed	-$690K	–	1607
2021 Q1	$690K	Sell	20,256 -13,711	-40%	-$524K	﹤0.01%	1075
2020 Q4	$1.13M	Sell	33,967 -347	-1%	-$12.7K	﹤0.01%	883
2020 Q3	$1.1M	Buy	34,314 +1,830	+6%	+$52.6K	0.01%	786
2020 Q2	$895K	Sell	32,484 -8,530	-21%	-$202K	﹤0.01%	884
2020 Q1	$657K	Buy	41,014 +15,831	+63%	+$375K	﹤0.01%	825
2019 Q4	$601K	Buy	25,183 +3,645	+17%	+$74.1K	﹤0.01%	974
2019 Q3	$380K	Buy	21,538 +1,040	+5%	+$20.1K	﹤0.01%	1072
2019 Q2	$525K	Hold	20,498	–	–	﹤0.01%	1025
2019 Q1	$596K	Buy	20,498 +3,690	+22%	+$95.6K	﹤0.01%	1030
2018 Q4	$221K	Sell	16,808 -47,065	-74%	-$751K	﹤0.01%	1184
2018 Q3	$1.29M	Sell	63,873 -18,807	-23%	-$425K	0.01%	784
2018 Q2	$1.96M	Buy	82,680 +8,400	+11%	+$216K	0.01%	699
2018 Q1	$1.67M	Buy	+74,280	New	+$1.95M	0.01%	684
2016 Q3	–	Sell	-33,150	Closed	-$327K	–	1247
2016 Q2	$327K	Buy	+33,150	New	+$387K	﹤0.01%	1024

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Los Angeles Capital Management's INSM Position: Q2 2026 in Review

Los Angeles Capital Management increased its Insmed (INSM) stake by 4,504% in Q2 2026, buying an estimated $5.1M and bringing the position to 43,092 shares worth $4.59M. The position accounts for 0.02% of the portfolio, ranked #438.

Los Angeles Capital Management first reported a position in INSM in Q2 2016 and has held it in 23 quarters since. The position peaked at $33.3M in Q2 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Los Angeles Capital Management held 43,092 shares of Insmed worth $4.59M as of Q2 2026.
Los Angeles Capital Management bought 42,156 Insmed shares in Q2 2026, an estimated $5.1M.
Insmed made up 0.02% of Los Angeles Capital Management's portfolio in Q2 2026, its #438 holding.
Los Angeles Capital Management first reported a position in Insmed in Q2 2016 and has held it in 23 quarters since.
Los Angeles Capital Management's Insmed position peaked at $33.3M in Q2 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.